Marpai (MRAI) Competitors

$2.10
+0.08 (+3.96%)
(As of 05/17/2024 ET)

MRAI vs. NMHI, ATER, APCX, PMEC, SWAG, GMM, HKIT, DLPN, AREN, and OG

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Nature's Miracle (NMHI), Aterian (ATER), AppTech Payments (APCX), Primech (PMEC), Stran & Company, Inc. (SWAG), Global Mofy Metaverse (GMM), Hitek Global (HKIT), Dolphin Entertainment (DLPN), The Arena Group (AREN), and Onion Global (OG). These companies are all part of the "business services" sector.

Marpai vs.

Marpai (NASDAQ:MRAI) and Nature's Miracle (NASDAQ:NMHI) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability.

49.8% of Marpai shares are held by institutional investors. Comparatively, 94.6% of Nature's Miracle shares are held by institutional investors. 61.3% of Marpai shares are held by insiders. Comparatively, 36.2% of Nature's Miracle shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Marpai has a beta of 5.39, suggesting that its stock price is 439% more volatile than the S&P 500. Comparatively, Nature's Miracle has a beta of -0.6, suggesting that its stock price is 160% less volatile than the S&P 500.

Marpai presently has a consensus target price of $6.00, suggesting a potential upside of 185.71%. Given Marpai's higher probable upside, research analysts plainly believe Marpai is more favorable than Nature's Miracle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nature's Miracle
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Marpai received 2 more outperform votes than Nature's Miracle when rated by MarketBeat users.

CompanyUnderperformOutperform
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Nature's MiracleN/AN/A

In the previous week, Nature's Miracle had 1 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Nature's Miracle and 1 mentions for Marpai. Nature's Miracle's average media sentiment score of 1.61 beat Marpai's score of 0.98 indicating that Nature's Miracle is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marpai
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Miracle
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Nature's Miracle has lower revenue, but higher earnings than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$37.15M0.58-$28.75M-$3.19-0.66
Nature's Miracle$8.93M2.00N/AN/AN/A

Nature's Miracle has a net margin of 0.00% compared to Marpai's net margin of -69.48%.

Company Net Margins Return on Equity Return on Assets
Marpai-69.48% N/A -68.67%
Nature's Miracle N/A N/A N/A

Summary

Marpai and Nature's Miracle tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$21.65M$2.42B$6.84B$7.96B
Dividend YieldN/A1.86%2.87%3.91%
P/E Ratio-0.6617.5321.5118.79
Price / Sales0.586.161,094.0477.89
Price / CashN/A11.3528.5731.98
Price / Book-1.493.404.864.76
Net Income-$28.75M$79.43M$116.69M$217.17M
7 Day Performance-6.25%-1.44%1.66%2.90%
1 Month Performance-9.87%-2.91%5.59%6.66%
1 Year Performance-19.22%-24.36%9.42%9.89%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMHI
Nature's Miracle
0 of 5 stars
$0.85
flat
N/AN/A$22.35M$8.93M0.0012News Coverage
Positive News
Gap Up
ATER
Aterian
0 of 5 stars
$2.90
-6.1%
N/A-60.9%$22.24M$142.57M-0.35114High Trading Volume
APCX
AppTech Payments
0 of 5 stars
$0.96
+3.2%
N/A-50.5%$23.58M$500,000.00-0.9518News Coverage
PMEC
Primech
0 of 5 stars
$0.67
-4.3%
N/AN/A$23.75MN/A0.003,133News Coverage
Positive News
Gap Down
SWAG
Stran & Company, Inc.
0 of 5 stars
$1.29
-4.4%
N/A-20.3%$24.01M$75.89M-64.50118Gap Down
GMM
Global Mofy Metaverse
0 of 5 stars
$0.93
-4.1%
N/AN/A$24.09M$26.89M0.0038Gap Up
HKIT
Hitek Global
0 of 5 stars
$1.46
+8.1%
N/A-84.3%$21.01M$4.56M0.0048News Coverage
Gap Up
DLPN
Dolphin Entertainment
0 of 5 stars
$1.13
-2.6%
N/A-42.3%$20.98M$43.12M-0.69245Upcoming Earnings
High Trading Volume
AREN
The Arena Group
0 of 5 stars
$0.84
-1.2%
N/A-79.4%$25.01M$244.20M-0.33441Earnings Report
OG
Onion Global
0 of 5 stars
N/AN/AN/A$25.02M$2.04B0.00796

Related Companies and Tools

This page (NASDAQ:MRAI) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners